Stay updated on CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.

Latest updates to the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page
- Check7 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.5%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.8%
- Check21 days agoChange DetectedThe web page has undergone significant updates, including the removal of specific eligibility criteria and treatment regimens for participants, which may affect the understanding of the study's requirements and protocols.SummaryDifference2%
- Check29 days agoChange DetectedThe page has been updated to include a new HHS Vulnerability Disclosure and has been revised to version 2.16.10, replacing the previous version 2.16.6. Additionally, a service alert regarding planned maintenance has been removed.SummaryDifference2%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.7%
- Check50 days agoChange DetectedA service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference1%
Stay in the know with updates to CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.